novelhealthstrategies.com

NOVEL Health Strategies' expertise in health economics and outcomes research and pharmaceutical pricing and market access at the global, regional and local levels help clients achieve market access.

http://www.novelhealthstrategies.com/

OVERVIEW OF novelhealthstrategies.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

12

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR NOVELHEALTHSTRATEGIES.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 11 reviews

5 star

6

4 star

2

3 star

1

2 star

0

1 star

2

Hey there! Start your review of novelhealthstrategies.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.6 seconds

FAVICON PREVIEW

16x16
32x32
64x64
128x128
160x160
192x192
256x256

CONTACTS AT NOVELHEALTHSTRATEGIES.COM

Saurabh Aggarwal

PO B●●●●1359

Sun●●●ale , CA, 94088

US

1.51●●●●2002

co●●●●●@myprivateregistration.com

View this contact

Admin PrivateRegContact

PO Box 61359 r●●●●●●●●●●●●●● accepted only

Sun●●●ale , CA, 94088

US

1.51●●●●2002

co●●●●●@myprivateregistration.com

View this contact

TECH PrivateRegContact

PO Box 61359 r●●●●●●●●●●●●●● accepted only

Sun●●●ale , CA, 94088

US

1.51●●●●2002

co●●●●●@myprivateregistration.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2011 March 24
UPDATED: 2014 March 24
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

13

YEARS
2

MONTHS
11

DAYS

NAME SERVERS

1: yns1.yahoo.com
2: yns2.yahoo.com

REGISTRAR

MELBOURNE IT, LTD. D/B/A INTERNET NAMES WORLDWIDE

WHOIS : whois.melbourneit.com

REFERRED : http://www.melbourneit.com

CONTENT

PAGES IN
THIS WEBSITE

12

SSL

EXTERNAL LINKS

4

SITE IP

66.96.149.32

LOAD TIME

0.563 sec

SCORE

6.2

PAGE TITLE

<META> DESCRIPTION

NOVEL Health Strategies' expertise in health economics and outcomes research and pharmaceutical pricing and market access at the global, regional and local levels help clients achieve market access.

<META> KEYWORDS

1 Pharmaceutical Market Access Strategy

2 Pharmaceutical Payer Strategy

3 Pharmaceutical Pricing and Reimbursement

4 Drug Pricing and Market Access

5 Pharmaceutical Pricing Strategy

6 NOVEL Health Strategies

7

8 coupons

9 reviews

10 scam

CONTENT

Page content here

KEYWORDS ON PAGE

get in touch,menu,expertise,publications,novel trends,ideas strategies results,our publications,our presentations,ehb market access,stroke nma,and speakers list,ights,reserved,health,trategies,strategies,results

SERVER

Apache/2

CONTENT-TYPE

iso-8859-1

GOOGLE PREVIEW

https://novelhealthstrategies.com

NOVEL Health Strategies' expertise in health economics and outcomes research and pharmaceutical pricing and market access at the global, regional and local levels help clients achieve market access.

INTERNAL PAGES

novelhealthstrategies.com

1

Thought Leadership | Novel Health Strategies | Annual Series Authored by Saurabh (Rob) Aggarwal

http://www.novelhealthstrategies.com/thoughtleadership.htm

Novel Health Strategies is celebrating the seventh year of its thought leadership in healthcare, with the recent publication in Nature Biotechnology, called 'What's fueling the biotech engine'. The strong foundation of thought leadership has enabled the Novel Health Strategies team to develop innovative, effective and efficient solutions for several drug and device manufacturers. These publications are the best examples of our team's strategic thinking, knowledge, quality and depth of our work. Latest Ov...

2

IPSOR Philadelphia| Novel Health Strategies Presenting 10 Studies at ISPOR

http://www.novelhealthstrategies.com/isporphilly.htm

NOVEL Health Strategies team is presenting 10 studies at ISPOR Annual Meeting in Philadelphia, PA on market access strategy, pricing and health economic and outcomes research trends. One of NOVEL's presentations was also selected for PODIUM PRESENTATION. These studies were led by Novel Health team and are good examples of wide breadth and depth of our expertise. In-person replays of all presentations are available upon request. PSS 32: PATIENT REPORTED OUTCOMES IN GLAUCOMA A SYSTEMATIC REVIEW.

3

http://www.novelhealthstrategies.com/index.htm

NATURE BIOTECHNOLOGY: Strategy Overview on BREAKTHROUGH Therapy Designations. NOVEL Selected for 10 Peer Reviewed Presentations at ISPOR 2015 Philadelphia. NOVEL Has Led More Than 200 Strategy Projects. NOVEL@AMCP CME Course and Presentations at AMCP. Recognized Leader for Drug and Device Strategy. Our Team in News. During 2011-2016 NOVEL's team was interviewed and quoted by The New York Times, Scientific American, Fast Company and Nature Medicine. AWARD Winning Study on Market Access Trends by NOVEL.

4

HTAi 2014 | Novel Health Strategies

http://www.novelhealthstrategies.com/dchtai2014.htm

Novel Health Strategies team was selected for podium and poster presentations at HTAi 2014 Annual Meeting in Washington, DC on market access strategy, pricing and health economic and outcomes research trends. These studies were led by Novel Health team and are good examples of wide breadth and depth of our expertise. In-person replays of all presentations are available upon request. PRICING AND MARKET ACCESS. Novel's team is presenting the following studies:. Date: June 16, 2014.

5

Publications | NOVEL Health Strategies | Saurabh (Rob) Aggarwal

http://www.novelhealthstrategies.com/pub.htm

NOVEL Health Strategies Won Two Poster Award Finalist Honor at ISPOR Milan. NOVEL Health Strategies Wins Another PLATINUM Medal award from AMCP (October 2015, PDF of the Award. NOVEL Health Strategies interviewed and quoted for market access challenges for Biosimilars: Regulations not the only barrier to biosimilars in the US say analysts (March 2015). NOVEL Health Strategies was interviewed and quoted by Fast Company for cover story on most innovative companies of 2015 (March 2015). Interview on Hepatit...

UPGRADE TO PREMIUM TO VIEW 7 MORE

TOTAL PAGES IN THIS WEBSITE

12

LINKS TO THIS WEBSITE

novelhealthstrategies.wordpress.com

Hepatitis C Drugs Rake in $21 Billion in Global Sales in 2015: NOVEL Health Strategies HCV Update | novelhealthstrategies

https://novelhealthstrategies.wordpress.com/2016/02/02/hepatitis-c-drugs-rake-in-21-billion-global-sales-in-2015-novel-health-strategies-hcv-update

Hepatitis C Drugs Rake in $21 Billion in Global Sales in 2015: NOVEL Health Strategies HCV Update. February 2, 2016. February 2, 2016. Market Insights by NOVEL Health Strategies. Official numbers are out. In 2015, the global sales of three Hep C blockbusters (Harvoni, Sovaldi and Viekira pak) reached almost $21 Billion. While this is a record, the peak sales are estimated to be more than $34 Billion. Good news for payers and patients! Worldwide who are infected with different genotypes of this virus.

novelhealthstrategies.wordpress.com

Market Insights by NOVEL Health Strategies | novelhealthstrategies

https://novelhealthstrategies.wordpress.com/author/novelhealthstrategies

Author: Market Insights by NOVEL Health Strategies. Benepali (Enbrel Biosimilar) Approved by Sweden HTA with 10% Discount: NOVEL Health Strategies Insights. March 21, 2016. March 21, 2016. Market Insights by NOVEL Health Strategies. Sweden Approval of Benepali. Today Sweden’s HTA agency approved Benepali for reimbursement at only 10% discount compared to Enbrel. This price discount is relatively low compared to typical price discounts for biosimilar ESAs and GM-CSFs. Norway’s Aggressive Price. Remicade i...

novelhealthstrategies.wordpress.com

February | 2016 | novelhealthstrategies

https://novelhealthstrategies.wordpress.com/2016/02

Hepatitis C Drugs Rake in $21 Billion in Global Sales in 2015: NOVEL Health Strategies HCV Update. February 2, 2016. February 2, 2016. Market Insights by NOVEL Health Strategies. Official numbers are out. In 2015, the global sales of three Hep C blockbusters (Harvoni, Sovaldi and Viekira pak) reached almost $21 Billion. While this is a record, the peak sales are estimated to be more than $34 Billion. Good news for payers and patients! Worldwide who are infected with different genotypes of this virus.

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

4

SOCIAL ENGAGEMENT

novelhealthstra

OTHER SITES

novelhead.com

Welcome!

Welcome to Bitrix Virtual Appliance! System is optimally configured and is ready to be used with "Bitrix Site Manager" and "Bitrix24". Please select one option below:.

novelhealing.com

Novel Healing | Novel Healing

novelhealth.com

NOVELHEALTH

novelhealthcare.com

The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).

novelhealthcareproducts.com

Under Construction

This site is under construction.

novelhealthstrategies.com

NATURE BIOTECHNOLOGY: Strategy Overview on BREAKTHROUGH Therapy Designations. NOVEL Selected for 10 Peer Reviewed Presentations at ISPOR 2015 Philadelphia. NOVEL Has Led More Than 200 Strategy Projects. NOVEL@AMCP CME Course and Presentations at AMCP. Recognized Leader for Drug and Device Strategy. Our Team in News. During 2011-2017 NOVEL's team was interviewed and quoted by The New York Times, Scientific American, Fast Company and Nature Medicine. AWARD Winning Study on Market Access Trends by NOVEL.

novelhealthstrategies.wordpress.com

novelhealthstrategies

Benepali (Enbrel Biosimilar) Approved by Sweden HTA with 10% Discount: NOVEL Health Strategies Insights. March 21, 2016. March 21, 2016. Market Insights by NOVEL Health Strategies. The pricing strategy for Biosimilars is still evolving. Few years ago it was assumed that Biosimilars would command low discount compared to small molecule generics. However, recent events illustrate two ends of the pricing spectrum for Biosimilars. Here we briefly discuss the two examples:. Sweden Approval of Benepali. Remica...

novelheartbeat.com

Novel Heartbeat – Book reviews, discussions & more!

Books I Didn’t Finish. Life of a Blogger. Welcome to the Family. Prequel & Sequel Challenge. Fur & Fangs Challenge. Love for Books Readathon. Beat the Heat Readathon. Book Signings & Events. Authors I’ve Seen. Subscribe to Novel Heartbeat. Click subscribe to get your daily dose of awesomeness straight to your inbox! The mind behind the blog. Novel Heartbeat on Instagram! Review: Sky in the Deep by Adrienne Young. What a kickass viking fantasy! The sense of family […]. Heartbeat Monthly (3): March 2018.

novelheights.wordpress.com

Novel Heights | Books, books and more books – what I've read & what I thought.

Books, books and more books – what I've read and what I thought. Star of the North – D B John. Star of the North. 8211; D. B. John. 8211; 10 May 2018. I’m not sure that in a bookshop, poised to part with a few pounds, I might have chosen a thriller set in North Korea, but I thoroughly enjoyed this book – blogging does broaden your horizons! Set in 2010 the book follows the fortunes of three main characters. Many thanks to the publisher for the review copy. A fascinating setting for a thriller. I read the...

novelhelpforme.mobi

Site Unavailable

This site is currently unavailable.

novelhelybra.blogspot.com

Mr. Novel Helybra

Rabu, 27 November 2013. Cara Menginstall Windows 7 (Lengkap dengan gambar). Masukkan DVD windows 7 atau colokkan flashdisk windows 7 kita, dan kemudian booting lah memakai media yang telah kita pilih, lalu proses loading file akan dimulai. Pilih bahasa Anda, waktu and format mata uang, keyboard atau metode input dan klik Next. Conteng I accept the license terms dan klik Next. Sekarang akan dimulai menginstal Windows 7. Langkah pertama, (yaitu Windows mulai menyalin file) sudah dilakukan ketika anda b...